From: The association between ADAM12 gene polymorphisms and osteoarthritis: an updated meta-analysis
Study author | Year | Country | Ethnicity | Sex | Number of samples | Age case/control (mean) | Genotyping method | Quality score | ||
---|---|---|---|---|---|---|---|---|---|---|
Cases | Controls | Total | ||||||||
Kerna et al. (1) [37] | 2009 | Estonian | European | Male | 40 | 60 | 100 | 32–55/NR | PCR–RFLP | 8 |
Female | 123 | 155 | 278 | 32–55/NR | ||||||
Rodriguez-Lopez et al. [40] | 2009 | Spain | European | Male | 51 | 179 | 230 | 68 (55–84)/68 (55–94) | Multiplex PCR | 6 |
Female | 211 | 115 | 326 | 68 (55–84)/68 (55–94) | ||||||
UK | European | Male | 164 | 342 | 506 | 65 (55–85)/69 (55–89) | Multiplex PCR | 6 | ||
Female | 196 | 356 | 552 | 65 (55–85)/69 (55–89) | ||||||
Greece | European | Male | 20 | 56 | 76 | 72 (62–85)/70 (46–88) | Multiplex PCR | 6 | ||
Female | 139 | 137 | 276 | 72 (62–85)/70 (46–88) | ||||||
Valdes et al | 2004 | UK | European | Female | 280 | 469 | 749 | 43–67/NR | PCR–SSCP | 5 |
Shin et al. [38] | 2012 | Korean | Asian | Male | 171 | 882 | 1053 | 67.4 ± 7.9/62.7 ± 7.9 | TaqMan | 7 |
Female | 554 | 855 | 1409 | 67.4 ± 7.9/62.7 ± 7.9 | ||||||
Kerna et al. (2) [26] | 2013 | Estonian | European | Male | 54 | 66 | 120 | 44.35.9/46.1 (5.5) | TaqMan | 8 |
Female | 131 | 143 | 274 | 44.35.9/46.1 (5.5) | ||||||
Lou et al. [39] | 2014 | China | Asian | Male | 58 | 77 | 135 | 63.1 ± 5.2/62.2 ± 4.2 | TaqMan | 9 |
Female | 94 | 102 | 196 | 63.1 ± 5.2/62.2 ± 4.2 | ||||||
Wang et al. [25] | 2015 | China | Asian | Male | 58 | 62 | 120 | 67.4 ± 4.2/65.9 ± 5.3 | iMLDR | 9 |
Female | 106 | 138 | 244 | 67.4 ± 4.2/65.9 ± 5.3 | ||||||
Poonpet et al. [41] | 2016 | Thai | Asian | Male | 53 | 51 | 104 | 69.0 ± 8.2/57.3 ± 5.8 | HRM-SNP | 7 |
Female | 147 | 149 | 296 | 69.0 ± 8.2/57.3 ± 5.8 | ||||||
Aguilar et al. [42] | 2020 | Mexico | North America | Male | 46 | 68 | 114 | 63.53 ± 14.52/55.98 ± 13.13 | TaqMan | 8 |
Female | 86 | 96 | 182 | 63.53 ± 14.52/55.98 ± 13.13 | ||||||
Haberal et al. [5] | 2021 | Turkish | European | Male | 42 | 26 | 48 | 66 ± 9.8/57.3 ± 11.2 | Real-time PCR | 8 |
Female | 108 | 124 | 232 | 66 ± 9.8/57.3 ± 11.2 | ||||||
Fatima et al. [24] | 2022 | Pakistan | Asian | Male | 88 | 100 | 188 | 50.45 ± 0.49/49.13 ± 0.53 | ARMS‐PCR | 8 |
Female | 312 | 300 | 612 | 50.45 ± 0.49/49.13 ± 0.53 |